Methods for detection of genetic disorders
CA 2517017 A1 · Owner: Ravgen, Inc. · Inventors: Dhallan, Ravinder
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a method useful for detection of genetic disorders. The method comprises determining the sequence of alleles of a locus of interest and quantitating a ratio for the alleles at the locus of interest wherein the , ratio indicates the presence or absence of a chromosomal abnormality. The present invention also provides a non-invasive method for the detection of chromosomal abnormalities in a fetus. The invention is especially useful as a non-invasive method for determining the sequence of fetal DNA. The invention further provides methods of isolation of free DNA from a sample.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 29, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 29, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 29, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.